Breakdown of the blood-brain barrier (BBB) may be an early biomarker of cognitive dysfunction, independent of amyloid or tau marker status, according to a study published online Jan. 14 in Nature Medicine....
French company CarThera has raised €9 million in its Series B funding round to help it develop ultrasound-based medical devices to treat brain disorders and overcome the challenges of the blood-brain barrier.
A new approach to getting drugs through the blood-brain barrier in Alzheimer's patients shows early promise, according to a study published online July 25 in Nature Communications. The research was published to coincide with the annual Alzheimer's Associa